- Home
- SILO vs HSDT Comparison
SILO vs HSDT Comparison
Compare SILO & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- HSDT
- Stock Information
- Founded
- SILO 2010
- HSDT N/A
- Country
- SILO United States
- HSDT United States
- Employees
- SILO N/A
- HSDT N/A
- Industry
- SILO Apparel
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SILO Consumer Discretionary
- HSDT Health Care
- Exchange
- SILO Nasdaq
- HSDT Nasdaq
- Market Cap
- SILO 5.9M
- HSDT 6.4M
- IPO Year
- SILO N/A
- HSDT N/A
- Fundamental
- Price
- SILO $0.68
- HSDT $7.38
- Analyst Decision
- SILO
- HSDT Hold
- Analyst Count
- SILO 0
- HSDT 1
- Target Price
- SILO N/A
- HSDT N/A
- AVG Volume (30 Days)
- SILO 289.1K
- HSDT 29.1K
- Earning Date
- SILO 08-13-2025
- HSDT 08-14-2025
- Dividend Yield
- SILO N/A
- HSDT N/A
- EPS Growth
- SILO N/A
- HSDT N/A
- EPS
- SILO N/A
- HSDT N/A
- Revenue
- SILO $72,102.00
- HSDT $295,000.00
- Revenue This Year
- SILO $1.86
- HSDT N/A
- Revenue Next Year
- SILO N/A
- HSDT $75.13
- P/E Ratio
- SILO N/A
- HSDT N/A
- Revenue Growth
- SILO N/A
- HSDT N/A
- 52 Week Low
- SILO $0.41
- HSDT $5.37
- 52 Week High
- SILO $3.37
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- SILO 55.60
- HSDT 44.61
- Support Level
- SILO $0.58
- HSDT $5.78
- Resistance Level
- SILO $0.65
- HSDT $6.11
- Average True Range (ATR)
- SILO 0.04
- HSDT 0.36
- MACD
- SILO 0.00
- HSDT 0.76
- Stochastic Oscillator
- SILO 83.31
- HSDT 93.02
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.